Arrhythmia

Selecting patients for idarucizumab (‘Praxbind’)

Wednesday, 2 Nov 2016


In the final video of the series Professor Pollack takes us through interim results from RE-VERSE AD which identified the types of patients suitable for dabigatran reversal with idarucizumab (Praxbind). 

 

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2022 the limbic